Acute phase proteins and systolic dysfunction in subjects with acute myocardial infarction

J Thromb Thrombolysis. 2008 Dec;26(3):196-202. doi: 10.1007/s11239-007-0088-7. Epub 2007 Nov 24.

Abstract

Aim: To investigate correlations between plasmatic concentrations of acute phase proteins (APPs) and left ventricular systolic function during the early phase of acute myocardial infarction.

Methods: Plasmatic concentrations of alpha-1-anti-trypsin (A1AT), alpha 1 glyco-protein (A1GP), haptoglobin (HG), caeruloplasmin (CP) and C-reactive protein (CRP) were evaluated in 123 patients with ST elevation acute myocardial infarction (STEMI) within 12 h after onset of chest pain. Systolic function was assessed with bi-dimensional echography and incidence of in-hospital adverse events was compared to APPs levels.

Results: A1AT, A1GP, HG and CP showed a statistically significant correlation with admission CRP concentrations (P < 0.001). Left ventricular ejection fraction inversely correlated with plasmatic concentrations of A1GP, A1AT, CP and HG. Incidence of acute heart failure correlated with values of APPs and, in a stepwise analysis, CP values were the most significant markers of acute heart failure.

Conclusions: Systolic dysfunction in STEMI patients seems to be associated with an inflammatory response featured by a rise in plasmatic concentration of APPs; increase in APPs concentrations seems to own a short-term prognostic relevance.

MeSH terms

  • Acute-Phase Proteins / metabolism*
  • Aged
  • Biomarkers / blood
  • Cohort Studies
  • Echocardiography
  • Female
  • Heart Failure, Systolic / blood*
  • Humans
  • Male
  • Middle Aged
  • Myocardial Infarction / blood*
  • Stroke Volume / physiology
  • Ventricular Dysfunction, Left / blood*

Substances

  • Acute-Phase Proteins
  • Biomarkers